Trial Profile
Study of the safety of SGLT-2 inhibitors for heart failure patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Feb 2018
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 11 Feb 2018 Status changed from recruiting to completed.
- 15 Sep 2015 New trial record